¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"abnormality of cell interaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • memory cell
    ¸é¿ª±â¾ï¼¼Æ÷
  • memory T cell
    ±â¾ïT¼¼Æ÷
  • Merkel cell-neurite complex
    ¸Þ¸£Ä̼¼Æ÷½Å°æµ¹±âº¹ÇÕ, Ã˰¢¼¼Æ÷½Å°æµ¹±âº¹ÇÕü
  • mesangial cell
    Ç÷°ü»çÀ̼¼Æ÷, ¸Þ»êÁö¿ò¼¼Æ÷
  • mesenchymal cell
    Áß°£¿±¼¼Æ÷
  • mesothelial cell
    ÁßÇǼ¼Æ÷
  • microglial cell
    ¹Ì¼¼¾Æ±³¼¼Æ÷, ¼Ò±³¼¼Æ÷
  • natural killer cell leukemia
    ÀÚ¿¬»ìÇØ¼¼Æ÷¹éÇ÷º´
  • nerve cell
    ½Å°æ¼¼Æ÷
  • nerve cell body
    ½Å°æ¼¼Æ÷ü
  • nerve cell process
    ½Å°æ¼¼Æ÷µ¹±â
  • neural crest cell
    ½Å°æ´É¼±¼¼Æ÷
  • neuroendocrine cell
    ½Å°æ³»ºÐºñ¼¼Æ÷
  • neuroepithelial cell
    ½Å°æ»óÇǼ¼Æ÷
  • neuroglial cell
    ½Å°æ¾Æ±³¼¼Æ÷, ½Å°æ±³¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • reserve cell
    ¿¹ºñ¼¼Æ÷
  • residential cell
    Á¤ÁÖ¼¼Æ÷
  • resting cell
    ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
  • reticular cell
    ±×¹°¼¼Æ÷
  • reticuloendothelial cell
    ±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
  • reticulum cell
    (¢¡reticular cell) ±×¹°¼¼Æ÷
  • rod cell
    ¸·´ë¼¼Æ÷
  • rod shaped cell
    ¸·´ë¸ð¾ç¼¼Æ÷
  • round cell
    ¿øÇü¼¼Æ÷
  • satellite cell
    À§¼º¼¼Æ÷
  • scavenger cell
    û¼Ò¼¼Æ÷
  • Schwann¡¯s cell
    ½Å°æÁý¼¼Æ÷
  • sensitized cell
    ¹Î°¨¼¼Æ÷
  • sensory cell
    °¨°¢¼¼Æ÷
  • septal cell
    Á߰ݼ¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • immunity,cell-mediated
    ¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
  • immunocompetent cell
    ¸é¿ªÀû°Ý¼¼Æ÷.
  • immunodeficiency syndrome, cell mediated
    ¼¼Æ÷¸Å°³ ¸é¿ª°áÇÌ ÁõÈıº
  • immunologically committed cell
    ¸é¿ª°æÇè¼¼Æ÷(¡­ÌèúÐá¬øà).
  • immunologically competent cell
    ¸é¿ªÀû°Ý¼¼Æ÷(¡­îêÌ«á¬øà).
  • immunologically performing cell
    ¸é¿ª¼öÇ༼Æ÷(¡­âÄú¼á¬øà).
  • indeterminate cell
    ºÎÁ¤Çü(ÜôïÒû¡) ¼¼Æ÷(á¬øà)
  • indifferent cell
    ¹«°ü¼¼Æ÷.
  • indirect cell division
    °£Á¢¼¼Æ÷ºÐ¿­.
  • inducer T cell
    À¯µµ T ¼¼Æ÷
  • inner cell mass
    ³»¼¼Æ÷A(Ò®á¬øàÎÔ).
  • inner cell mass (embryoblast)
    ¼Ó¼¼Æ÷µ¢ÀÌ ¹èÀÚ¸ðü
  • inner cell mass embryoblast
    ¼Ó¼¼Æ÷µ¢ÀÌ ¹èÀÚ¸ðü
  • inner hair cell
    ³»À¯¸ð¼¼Æ÷(Ò®êáÙ¾á¬øà).
  • inner hair cell
    ¼ÓÅм¼Æ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • cell typing
    Ç÷±¸Çü°Ë»ç
  • cell wall
    ¼¼Æ÷º®
  • cell wall
    ¼¼Æ÷º®.
  • cell wall antigen
    ¼¼Æ÷º®Ç׿ø
  • cell wall inhibitor
    ¼¼Æ÷º®ÇÕ¼º¾ïÁ¦Á¦
  • cell wall teichoic acid
    ¼¼Æ÷º® ŸÀÌÄÚ»ê
  • cell, HeLa
    HeLa¼¼Æ÷
  • cell, K
    K¼¼Æ÷, »ìÇØ¼¼Æ÷
  • cell, T
    T¼¼Æ÷
  • cell, committed T
    ¼öÀÓT¼¼Æ÷
  • cell, dendritic
    ¼öÁö»ó¼¼Æ÷
  • cell, dendritic reticular <-lum>
    ¼öÁö¸Á»ó¼¼Æ÷
  • cell, diploid
    À̹èü¼¼Æ÷
  • cell, educated T
    ¸é¿ªµÈT¼¼Æ÷
  • cell, epithelioid
    À¯»óÇǼ¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CTCL Cutaneous T Cell Lymphoma
ENKAF Epidermal-derived NK cell-Activating Factor
ETAF Epidermal cell derived Thymocyte Activating Factor
GIP   1) Giant cell Interstitial Pneumonia
  2) Gastric Inhibitory (Poly)Peptide
HDCV Human Diploid Cell Vaccine; Àΰ£ À̹èü ¼¼Æ÷ ¹é½Å
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
BAEC Bovine aortic endothelial cell
BLEC bovine lens epithelial cell
BOSCC Bovine ocular squamous cell carcinoma
BOEC Bovine oviduct epithelial cell
BREC bovine retinal endothelial cell
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • prickle cell carcinoma
    ±Ø¼¼Æ÷ ¾Ï
  • prickle cell layer
    ±Ø¼¼Æ÷ Ãþ, À¯±Ø ¼¼Æ÷Ãþ, °¡½ÃÃþ, À¯±ØÃþ
    ÀÎÁ¢ ¼¼Æ÷¿Í ¼¼Æ÷°£±³¸¦ Çü¼ºÇϰí ÀÖ´Â °¢È­ ±¸°­ »óÇÇÀÇ ÇÑ ¼¼Æ÷Ãþ.
  • primary afferent cell body
    ÀÏÂ÷ ±¸½É¼º ¼¼Æ÷ü
  • primitive myoid cell
    ¿ø½Ã ±Ù ¼Ò¼¼Æ÷
  • primordial germ cell
    ¿ø½Ã »ý½Ä¼¼Æ÷, ½Ã¿ø »ý½Ä ¼¼Æ÷
    »ý¹°ÀÇ ¹ß»ý Ãʱ⿡ ÀåÂ÷ »ý½Ä¼Ò·Î ºÐÈ­µÉ ¿¹Á¤ÀÎ ¼¼Æ÷¿ª¿¡ À־ÀÇ ¹ÌºÐÈ­ »ý½Ä ¼¼Æ÷. ¿ø½Ã »ý½Ä ¼¼Æ÷, ½Ã¿ø¼º ¼¼Æ÷¶ó°íµµ ÇÑ´Ù. ¹ß»ýÀÌ ÁøÇàµÇ¸é »ý½Ä¼ÒÀÇ ³­¿ø ¼¼Æ÷ ¶Ç´Â Á¤¿ø ¼¼Æ÷·Î ºÐÈ­ÇÑ´Ù. ½Ã¿ø »ý½Ä ¼¼Æ÷´Â ´Ù¸¥ Á¶Á÷ ¼¼Æ÷¿Í ±¸º°µÇ´Â ÇüÅÂÀû Ư¡À» °¡Áö¸ç, ¶ÇÇÑ »ý½Ä¼ÒÀÇ ¿¹Á¤¿ªº¸´Ù »ó´çÈ÷ ¶³¾îÁø ¹è¿ª¿¡ Á¸ÀçÇÑ´Ù. ÀÌ ¹è¿ª¿¡ Àå¾Ö¸¦ ÁÖ¸é »ý½Ä ¼¼Æ÷ÀÇ ºÐÈ­°¡ ÀϾÁö ¾Ê°Ô µÈ´Ù. ½Ã¿ø »ý½Ä ¼¼Æ÷´Â ü¼¼Æ÷¿Í´Â ¸í¹éÇÏ°Ô ±¸º°µÇ¸ç, ü¼¼Æ÷·ÎºÎÅÍ ½Ã¿ø »ý½Ä ¼¼Æ÷·Î ºÐÈ­µÇÁö ¾Ê´Â´Ù°í ÇÏ´Â »ý½ÄÁú ¿¬¼Ó¼³ÀÌ ÀϹÝÀûÀ¸·Î ÀÎÁ¤µÇ°í ÀÖ´Ù. ¿¹¸¦ µé¸é, ¸»È¸ÃæÀº 2°³ÀÇ ¿°»öü¸¦ °¡Áö´Âµ¥, À̰ÍÀº ÃÖÃÊÀÇ ³­ºÐÇÒ ¶§ºÎÅÍ »ý½Ä ¼¼Æ÷°è¿Í ü¼¼Æ÷°è·Î ³ª´©¾îÁø´Ù. »ý½Ä ¼¼Æ÷°è´Â 2°³ÀÇ ¿°»öü¸¦ °¡Áö°í ¿¬¼ÓÇÏÁö¸¸, ü¼¼Æ÷°è´Â ¿°»öü¿¡ Àý´ÜÀÌ ÀϾ¼­ ´Ù¼öÀÇ ¿°»öü ¼ö¸¦ °¡Áö´Â ¼¼Æ÷°è·Î ºÐÈ­ÇÑ´Ù.
  • principal cell
    ÁÖ ¼¼Æ÷
  • projection cell
    Åõ»ç ¼¼Æ÷
  • proliferating cell pool

    proliferating pleurisy (Áõ½Ä¼º È丷¿°

  • pyknotic endothelial cell
    ³óÃà ÇÙ ³»ÇÇ ¼¼Æ÷
  • pyramidal cell
    ÇǶó¹Ô ¼¼Æ÷, Ãßü ¼¼Æ÷, ÇǶó¹Ô ¸ð¾ç ¼¼Æ÷
    ºÎ¼öµÈ ¼¶À¯¿Í °°ÀÌ Ãßü ½Å°æ¿øÀ» ±¸¼ºÇϰí ÀÖ´Â ´ë³ú ÇÇÁúÀÇ Å©°í ´Ù±Ø¼ºÀÎ ÃßüÇü ½Å°æÀý ¼¼Æ÷ÀÇ Çϳª.
  • R-S cell
    ¸®µå-½ºÅÙ¹ö±× ¼¼Æ÷
    È£µåŲ½ºº´¿¡¼­ ³ªÅ¸³ª´Â ´ÙÇÙ °Å´ë ¼¼Æ÷.
  • red blood cell
    ÀûÇ÷±¸
    µ¿ÀǾî=erythrocyte. »ê¼Ò³ª ÀÌ»êȭź¼Ò¸¦ ¿î¹ÝÇÏ´Â Ç÷¾× ³»¿¡ Á¸ÀçÇÏ´Â Ç÷±¸.
  • red cell volume
    ÀûÇ÷±¸ ¿ëÀû
    ü³»ÀÇ ÃÑÀûÇ÷±¸ ¿ë·®À¸·Î¼­ ¹æ»ç´É µ¿À§¿ø¼Ò·Î ÃøÁ¤ÇÑ´Ù.
  • Reed-sternberg cell
    ¸®µå-½ºÅϹö±× ¼¼Æ÷
    Hodgkinº´¿¡ Ư¡ÀûÀÎ Ä¿´Ù¶õ ÀÌÇü Á¶Á÷±¸ÀÌ´Ù. ÀüÇüÀûÀÎ ¼¼Æ÷´Â ´ã¿°¼ºÀÇ È£»ê¼º ¼¼Æ÷ÁúÀ» °¡Áö¸ç, 1-2°³ÀÇ ´ëÇü ÇÙ ¶Ç´Â Áö³ªÄ¡°Ô ºÐ¿±ÇÑ ÇÙÀ» °®´Â´Ù. ±× ÇÙÀº º¯¿¬ºÎ¿¡´Â ¿°»öÁúÀÇ µ¢¾î¸®¿Í ºñÁ¤»óÀûÀ¸·Î ÇöÀúÇÑ È£»ê¼ºÀÇ ÇÙ¼Òü¸¦ °¡Áö°í ÀÖ´Ù. ÀÌÇÙ¼ºÀÇ °ÍÀº °¡²û °æ»óÇüÀ» ³ªÅ¸³½´Ù.
  • renal cell carcinoma
    ½Å ¼¼Æ÷ ¾ÏÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
cell-mediated immunity <immunology> Immune response that involves effector T lymphocytes and not the production of humoral antibody.
Responsible for allograft rejection, delayed hypersensitivity and in defence against viral infection and intracellular protozoan parasites.
(26 Mar 1998)
cell-mediated reaction Immunological reaction of the delayed type, involving chiefly T lymphocytes, important in host defense against infection, in autoimmune diseases, and in transplant rejection.
See: skin test.
(05 Mar 2000)
cell membrane <cell biology> The structure enveloping a cell, enclosing the cytoplasm and forming a selective permeability barrier.
It consists of lipids, proteins and some carbohydrates, the lipids thought to form a bilayer in which integral proteins are embedded to varying degrees.
Synonym: plasma membrane.
(26 Mar 1998)
cell membrane permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.
(12 Dec 1998)
cell migration <cell biology> Implies movement of a population of cells from one place to another as in the movement of neural crest cells during morphogenesis.
(26 Mar 1998)
cell migration inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated leukocytes or macrophages. Specific assays have been developed to estimate levels of migration-inhibitory factor, immune reactivity against tumour-associated antigens, and immunosuppressive effects of infectious microorganisms.
(12 Dec 1998)
cell movement <cell biology> A more general term than locomotion, that can include shape change, cytoplasmic streaming etc.
(26 Mar 1998)
cell nucleolus Within most types of eukaryotic cell nucleus, a distinct region, not delimited by a membrane, in which some species of rrna (RNA, ribosomal) are synthesised and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rrna is transcribed from a nucleolar organiser, i.e., a group of tandemly repeated chromosomal genes which encode rrna and which are transcribed by RNA polymerase I.
(12 Dec 1998)
cell nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (cell nucleolus). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the endoplasmic reticulum. A cell may contain more than one nucleus.
(12 Dec 1998)
P cell A characteristic specialised cell, with probable pacemaker function, found in the S-A node and A-V junction.
(05 Mar 2000)
cell organelle <cell biology> A structurally discrete component of a cell.
(18 Nov 1997)
cell physiology Characteristics and physiological processes of cells from cell division to cell death.
(12 Dec 1998)
cell plate <plant biology> Region in which the new cell wall forms after the division of a plant cell.
In the plane of the equator of the spindle a disc like structure, the phragmoplast forms, into which are inserted pole derived microtubules. Golgi derived vesicles containing pectin come together and fuse at the plate which develops from the centre outwards and eventually fuses with the plasma membrane thereby separating the daughter cells.
(26 Mar 1998)
cell polarity 1. <cell biology> In epithelial cells the differentiation of apical and basal specialisations. In many epithelia the apical and baso lateral regions of plasma membrane differ in lipid and protein composition and are isolated from one another by tight junctions. The apical membrane may, for example: be the only region where secretory vesicles fuse or have a particular ionic pumping system.
2. A motile cell must have some internal polarity in order to move in one direction at a time: a region in which protrusion will occur (the front) must be defined. Locomotory polarity may be associated with the pericentriolar microtubule organising centre and can be perturbed by drugs that interfere with microtubule dynamics.
(26 Mar 1998)
cell potential <cell biology, physiology> The voltage of an electrochemical cell, the larger the cell potential, the greater the extent of reaction when equilibrium is reached.
(26 Mar 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á